HYPERGLYCEMIA AND GLUCAGON SUPPRESSION - POSSIBLE IMPORTANCE OF THE VAGUS AND ENTERIC HUMORAL-FACTORS

被引:10
作者
FINDLAY, DM
OMOND, S
ALFORD, FP
CHISHOLM, DJ
机构
[1] UNIV MELBOURNE, ST VINCENTS HOSP, ENDOCRINOL UNIT, FITZROY 3065, VICTORIA, AUSTRALIA
[2] UNIV MELBOURNE, ST VINCENTS HOSP, DEPT MED, FITZROY 3065, VICTORIA, AUSTRALIA
关键词
D O I
10.1210/jcem-48-1-13
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Augmentation of insulin release after oral glucose by a gastrointestinal humoral mechanism is well accepted. The suggestion of a similar mechanism for suppression of glucagon release after oral glucose has not been previously tested. In this study, plasma glucagon levels have been estimated in five normal subjects after both oral and iv administration of glucose. A variable iv glucose infusion rate with frequent monitoring of blood glucose was used to match the hyperglycemia produced by the 50 g oral glucose and the iv glucose loads. Virtually complete suppression of plasma glucagon levels was seen in both cases (nadir of glucagon levels 16 ± 6 pg/ml for oral glucose; 11.4 ± 3 pg/ml for iv glucose). Thus, enteric humoral factors did not facilitate glucagon suppression after oral glucose ingestion in man. The vagus nerve is also involved in mediating the a-cell response to hypoglycemia and, thus, to examine whether hyperglycemia suppresses glucagon release through a vagal mechanism, iv atropine (15 μg/kg) was given 20 min before administration of oral or iv glucose. Atropinization delayed the glucagon suppression after oral glucose, but this delay was probably related to delayed glucose absorption from the gut. With iv glucose, atropinization did not affect the degree of suppression of glucagon levels. It is concluded that a-cell suppression in response to hyperglycemia is not mediated via the vagus. © 1979 by The Endocrine Society.
引用
收藏
页码:13 / 16
页数:4
相关论文
共 11 条
[1]   GLUCAGON LEVELS IN NORMAL AND DIABETIC SUBJECTS - USE OF A SPECIFIC IMMUNOABSORBENT FOR GLUCAGON RADIOIMMUNOASSAY [J].
ALFORD, FP ;
BLOOM, SR ;
NABARRO, JDN .
DIABETOLOGIA, 1977, 13 (01) :1-6
[2]  
BLOOM SR, 1974, LANCET, V2, P546
[3]  
Brown J C, 1975, Recent Prog Horm Res, V31, P487
[4]   MONOIODOINSULIN - DEMONSTRATION OF ITS BIOLOGICAL ACTIVITY AND BINDING TO FAT CELLS AND LIVER MEMBRANES [J].
FREYCHET, P ;
ROTH, J ;
NEVILLE, DM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1971, 43 (02) :400-&
[5]  
GOCHMAN N, 1972, CLIN CHEM, V18, P943
[6]   COATED CHARCOAL IMMUNOASSAY OF INSULIN [J].
HERBERT, V ;
LAU, KS ;
GOTTLIEB, CW ;
BLEICHER, SJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1965, 25 (10) :1375-+
[7]   INTESTINAL FACTORS IN CONTROL OF INSULIN SECRETION [J].
MCINTYRE, N ;
HOLDSWORTH, CD ;
TURNER, DS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1965, 25 (10) :1317-+
[8]   ABNORMAL ALPHA-CELL FUNCTION IN DIABETES - RESPONSE TO CARBOHYDRATE AND PROTEIN INGESTION [J].
MULLER, WA ;
FALOONA, GR ;
AGUILARP.E ;
UNGER, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 1970, 283 (03) :109-&
[9]   PLASMA INSULIN RESPONSES TO ORAL AND INTRAVENOUS GLUCOSE - STUDIES IN NORMAL AND DIABETIC SUBJECTS [J].
PERLEY, MJ ;
KIPNIS, DM .
JOURNAL OF CLINICAL INVESTIGATION, 1967, 46 (12) :1954-&
[10]   STUDIES OF PANCREATIC ALPHA CELL FUNCTION IN NORMAL AND DIABETIC SUBJECTS [J].
UNGER, RH ;
AGUILARP.E ;
MULLER, WA ;
EISENTRAUT, AM .
JOURNAL OF CLINICAL INVESTIGATION, 1970, 49 (04) :837-+